Where to Buy Semaglutide in 2026

Research semaglutide is no longer offered by verified suppliers. After its delisting mid-2026 at CertaPeptides, no verified supplier (CertaPeptides, SwissChems, AminoClub) lists it anymore. There is therefore no verified purchase option for research semaglutide.

The only GLP-1 peptide still available at our verified European supplier is retatrutide, a triple agonist of the GIP / GLP-1 / glucagon receptors. We present it as the available, verified GLP-1 research alternative.

Important: Retatrutide is a compound strictly for research, not intended for human consumption. Pharmaceutical versions of semaglutide (Ozempic, Wegovy, Rybelsus) are available by prescription only.

CertaPeptides is a European supplier based in Romania, specializing in research peptides. Semaglutide has no longer been listed there since mid-2026; the only GLP-1 peptide still available at this verified supplier is retatrutide, a triple agonist of the GIP / GLP-1 / glucagon receptors.

Strengths

• Fast European shipping — 3-7 business days within the EU (Germany, France, Spain, Italy...)
• Guaranteed 98%+ HPLC purity — HPLC and MS testing with each batch
• Independent Certificate of Analysis (CoA) — Janoshik / Finnrick, up to 99.90% HPLC
• No additional VAT — Prices include taxes for the EU
• Secure payment — Credit card and crypto accepted

Considerations

• Europe shipping only (no shipping to USA or Asia)
• Return policy limited to 14 days
• Stock sometimes limited due to high demand

Available GLP-1 Product

Retatrutide is a compound strictly for research, not intended for human consumption. To explore the other available GLP-1/incretin compounds, browse the GLP-1 category.

Since mid-2026, research semaglutide has been fully delisted at verified suppliers. CertaPeptides removed it from its catalog (its former product URLs now redirect to the category page), and neither SwissChems nor AminoClub ever listed it. No verified purchase option remains.

Why the Delisting?

• Likely regulatory withdrawal — Semaglutide is a molecule commercialized in pharmaceutical form (Novo Nordisk: Ozempic, Wegovy, Rybelsus), which exposes its research version to increased scrutiny
• Complex molecule — A 31 amino acid peptide with a specific lipid modification, expensive to synthesize
• High demand — The popularity of Ozempic/Wegovy treatments has created regulatory pressure

Availability at Verified Suppliers

The only GLP-1 peptide still available at a verified supplier is retatrutide, offered by CertaPeptides in Europe.

Semaglutide is a synthetic peptide in the class of GLP-1 receptor agonists (glucagon-like peptide-1). It is the subject of intensive research in several fields:

Research Areas

• Weight management — STEP clinical trials showed significant results in obesity research
• Glucose metabolism — Study of mechanism of action on glucose-dependent insulin secretion
• Cardiovascular health — SELECT trial studied effects on cardiovascular events
• Neuroprotection — Emerging research on potential effects on the central nervous system

Molecular Characteristics

For more information on mechanism of action and clinical studies, see our complete semaglutide guide.

Since semaglutide is a complex and expensive molecule, it is essential to verify supplier quality:

1. Certificate of Analysis (CoA)

A serious supplier provides a batch-specific CoA. This document should include:

• HPLC chromatogram showing purity (98%+ minimum)
• Mass spectrometry (MS) confirming exact molecular weight (4113.58 g/mol)
• Endotoxin testing
• Batch number matching the label

2. Storage and Shipping

Semaglutide is temperature sensitive:

• Optimal storage at -20C
• Shipping with ice packs or dry ice
• Insulated packaging required

3. Reference Pricing

Quality research semaglutide costs between EUR25 and EUR60 for 5mg. A significantly lower price is a warning sign.

4. Red Flags to Avoid

• No CoA available
• Abnormally low prices (
• Sellers without verifiable history
• Sites without clear legal information